London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950
info@mrcplast.com

Our Clients

Order Informer

 
Home > News >
 

Evonik develops worlds first free-flowing bioresorbable powder for the 3D printing of implantable medical devices

February 17/2020

MOSCOW (MRC) -- German industrial chemical corporation Evonik has developed a Selective Laser Sintering (SLS) bioresorbable powder designed to create 3D printed implantable medical devices, said the company.

Known as RESOMER PrintPowder, this material has been created to produce strong, durable parts with stress shielding capabilities to prevent bone loss as a result of an implant. Dr. Jean-Luc Herbeaux, SVP and General Manager of the Health Care business line, stated: The free-flowing processability of RESOMER PrintPowder will, for the first time, allow medical device companies to utilize SLS 3D printing technologies to create complex bioresorbable implants with precisely tailored mechanical properties."

Under the Nutrition & Care segment of Evonik, the Health Care business line, serves over 1000 pharmaceutical, nutraceutical, and medical device customers. Within this sector is the RESOMER portfolio of bioresorbable polymers which features semi-crystalline and amorphous polymers. Previously, Evonik released RESOMER Filaments, a series of bioresorbable materials for FFF/FDM.

As the latest addition to the RESOMER line, PrintPowder can be used to fabricate 3D printed Craniomaxillofacial (CMF) plates, spinal fusion cages, scaffolds for soft tissue repair and dental meshes. According to Evonik, this material can improve patient healing and device performance across orthopedic, dental and soft tissue application areas.

As MRC informed earlier, Evonik joined with other manufacturers in the High Phthalates Panel (HPP), a sector group of the American Chemistry Council (ACC), in a voluntary manufacturer request to the US Environmental Protection Agency (EPA) to conduct a broad-based risk evaluation of the uses of DINP. The EPA granted the request in early December 2019, a decision welcomed by Evonik. The EPAs risk evaluation will be performed using the best available science and weight of scientific evidence. The process will be documented and open for public review and comment.

As per MRC's ScanPlast, Russia's overall production of polyvinyl chloride (PVC) reached 975,000 tonnes in 2019, up by 2% year on year. At the same time, not all Russian producers raised their output. December total production of unmixed PVC was about 81,400 tonnes versus 84,600 tonnes a month earlier, RusVinyl decreased their capacity utilisation in November. Overall PVC production reached 975,000 tonnes in January-December 2019, compared to 958,600 tonnes a year earlier. All plants raised their output, except for Kaustik Volgograd.

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evoniks corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of EUR13.3 billion and an operating profit (adjusted EBITDA) of EUR2.15 billion from continuing operations.

Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.


mrcplast.com
Author:Anna Larionova
Tags:petroleum products, compounding, compounds, petrochemistry, coatings, Evonik.
Category:General News
|
| More

Leave a comment

MRC help

 


 All News   News subscribe